English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Press release submission
| Apr 25, 2019
PROVENTION BIO, INC.: Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease
Press release submission
| Apr 23, 2019
ELI LILLY AND COMPANY: Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Press release submission
| Apr 19, 2019
TELA BIO, INC.: Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery
Press release submission
| Apr 15, 2019
MESOTHELIOMA COMPENSATION CENTER: Now Offers to Make Certain That a Nuclear Power Worker with Mesothelioma or Asbestos Exposure Lung Cancer Gets Accelerated Compensation with The Help of Attorney Erik Karst and His Colleagues at Karst von Oiste
Press release submission
| Apr 11, 2019
BD: Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
Press release submission
| Apr 10, 2019
TREMOTYX BIOMEDICAL LAB: Debuts Plant Stem Cell-Based Eczema Treatment in the U.S.
Press release submission
| Apr 4, 2019
VARIAN MEDICAL SYSTEM: Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Press release submission
| Apr 4, 2019
GENOME MEDICAL: Renown Health and Genome Medical Partner to Bring Genetic Counseling and Educational Services to Patients for End-to-End Genetic Testing Support
Trending
Patient Daily
| Jul 8, 2025
Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+
Pharmaceuticals
Patient Daily
| Jul 8, 2025
Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily
| Jul 9, 2025
FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
« First
«
…
98
99
100
101
102
103
104
…
»
Last »